Loading…
2 companies · GEL, thousands · columns ordered by revenue
Only 1 of 2 peers filed FY2024. Switch to FY2023 (2 of 2).
| Line item | DSMTS - Damokidebulebis… | Eiem Group |
|---|---|---|
| Total Revenue | 9,838 | — |
| Total COGS | -6,925 | — |
| Gross Profit | 2,913 | — |
| Gross Margin | 29.6% | — |
| Total Operating Expenses | -1,520 | — |
| EBITDA | 1,393 | — |
| EBITDA Margin | 14.2% | — |
| Total D&A | -114 | — |
| EBIT / Operating Income | 1,279 | — |
| Total Interest Income | 3 | — |
| Total Interest Expense | -136 | — |
| Total Other Income | -127 | — |
| Profit Before Tax | 1,020 | — |
| Total Income Tax | -355 | — |
| Net Profit / (Loss) | 665 | — |
| Net Margin | 6.8% | — |
Not every picked company reports every selected year — FY2024: no filing for Eiem Group. Those cells are left blank (no filing), not zero.
| Company | Sector | EBITDA margin · FY 2024 | Percentile | Sector n |
|---|---|---|---|---|
| DSMTS - Damokidebulebis… | Healthcare Services | 14.2% | 63rd pct | 268 |
| Eiem Group | (unclassified) | — | no FY data | 1208 |
Percentile is within each company's own sector across the whole FY2024 cross-section (1st–100th; higher = larger value). Companies with no sector, or no filing for the year, are not ranked.